Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Absci Corporation stock logo
ABSI
Absci
$3.12
+8.3%
$2.78
$2.01
$6.33
$397.98M2.013.01 million shs8.71 million shs
Concorde International Group Ltd. stock logo
CIGL
Concorde International Group
$3.73
+3.6%
$8.46
$2.12
$31.06
$82.58MN/A780,323 shs127,023 shs
National Research Corporation stock logo
NRC
National Research
$14.22
-4.9%
$15.30
$9.76
$27.07
$324.01M0.4589,789 shs77,099 shs
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
$18.45
-1.3%
$20.43
$15.72
$25.01
$336.29M0.5168,066 shs43,572 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Absci Corporation stock logo
ABSI
Absci
0.00%+16.85%+13.45%+0.97%-28.77%
Concorde International Group Ltd. stock logo
CIGL
Concorde International Group
0.00%-11.40%-42.79%+372,999,900.00%+372,999,900.00%
National Research Corporation stock logo
NRC
National Research
0.00%-10.90%-15.51%+34.91%-42.12%
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
0.00%-3.25%-9.16%+1,844,999,900.00%+1,844,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Absci Corporation stock logo
ABSI
Absci
1.749 of 5 stars
3.51.00.00.01.11.70.6
Concorde International Group Ltd. stock logo
CIGL
Concorde International Group
N/AN/AN/AN/AN/AN/AN/AN/A
National Research Corporation stock logo
NRC
National Research
2.4789 of 5 stars
0.04.01.70.01.82.51.3
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
0.1795 of 5 stars
0.00.00.80.01.12.50.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Absci Corporation stock logo
ABSI
Absci
3.00
Buy$8.40169.23% Upside
Concorde International Group Ltd. stock logo
CIGL
Concorde International Group
0.00
N/AN/AN/A
National Research Corporation stock logo
NRC
National Research
0.00
N/AN/AN/A
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest CIGL, NRC, TRAK, and ABSI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/3/2025
Absci Corporation stock logo
ABSI
Absci
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$7.00
5/14/2025
Absci Corporation stock logo
ABSI
Absci
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00 ➝ $9.00
(Data available from 7/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Absci Corporation stock logo
ABSI
Absci
$4.53M87.86N/AN/A$1.56 per share2.00
Concorde International Group Ltd. stock logo
CIGL
Concorde International Group
$10.49M7.87N/AN/AN/A
National Research Corporation stock logo
NRC
National Research
$143.06M2.26$1.34 per share10.65$1.36 per share10.46
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
$20.45M16.49$0.40 per share46.52$2.57 per share7.18
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Absci Corporation stock logo
ABSI
Absci
-$103.11M-$0.920.00N/AN/A-2,232.13%-53.69%-45.89%8/13/2025 (Estimated)
Concorde International Group Ltd. stock logo
CIGL
Concorde International Group
-$83.64MN/A0.00N/AN/AN/AN/AN/A
National Research Corporation stock logo
NRC
National Research
$24.78M$1.0313.81N/A17.14%71.33%18.67%7/28/2025 (Estimated)
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
$5.96M$0.3454.12N/A30.13%13.89%12.44%N/A

Latest CIGL, NRC, TRAK, and ABSI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
Absci Corporation stock logo
ABSI
Absci
-$0.19N/AN/AN/A$1.39 millionN/A
5/13/2025Q1 2025
Absci Corporation stock logo
ABSI
Absci
-$0.23-$0.21+$0.02-$0.21$1.07 million$1.18 million
4/28/2025Q1 2025
National Research Corporation stock logo
NRC
National Research
N/A$0.25N/A$0.25N/A$33.55 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Absci Corporation stock logo
ABSI
Absci
N/AN/AN/AN/AN/A
Concorde International Group Ltd. stock logo
CIGL
Concorde International Group
N/AN/AN/AN/AN/A
National Research Corporation stock logo
NRC
National Research
$0.483.38%N/A46.60%N/A
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
$0.070.38%N/A20.59%2 Years

Latest CIGL, NRC, TRAK, and ABSI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/5/2025
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
quarterly$0.020.37%9/30/20259/30/202511/14/2025
6/20/2025
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
quarterly$0.01820.36%6/30/20256/30/20258/14/2025
4/25/2025
National Research Corporation stock logo
NRC
National Research
quarterly$0.124.1%6/27/20256/27/20257/11/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Absci Corporation stock logo
ABSI
Absci
N/A
5.72
5.72
Concorde International Group Ltd. stock logo
CIGL
Concorde International Group
1.36
1.17
1.17
National Research Corporation stock logo
NRC
National Research
1.98
0.54
0.54
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
0.01
6.03
6.03

Institutional Ownership

CompanyInstitutional Ownership
Absci Corporation stock logo
ABSI
Absci
52.05%
Concorde International Group Ltd. stock logo
CIGL
Concorde International Group
N/A
National Research Corporation stock logo
NRC
National Research
47.26%
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
27.35%

Insider Ownership

CompanyInsider Ownership
Absci Corporation stock logo
ABSI
Absci
10.49%
Concorde International Group Ltd. stock logo
CIGL
Concorde International Group
N/A
National Research Corporation stock logo
NRC
National Research
2.00%
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
44.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Absci Corporation stock logo
ABSI
Absci
210127.56 million114.18 millionOptionable
Concorde International Group Ltd. stock logo
CIGL
Concorde International Group
13422.14 millionN/AN/A
National Research Corporation stock logo
NRC
National Research
49022.78 million22.33 millionOptionable
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
7018.28 million10.24 millionN/A

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Absci stock logo

Absci NASDAQ:ABSI

$3.12 +0.24 (+8.33%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$3.14 +0.01 (+0.48%)
As of 07/18/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.

Concorde International Group stock logo

Concorde International Group NASDAQ:CIGL

$3.73 +0.13 (+3.61%)
As of 07/18/2025 04:00 PM Eastern

Concorde International Group Limited is an integrated security services providers that combines physical manpower and innovative technology to deliver effective security solutions. In 2014, we were awarded “The Business Model Innovation Award” by the Singapore Manufacturing Federation. In 2015, we were awarded the “Best Innovative Use of Infocomm Technology Award” by the Singapore Infocomm Technology Federation (“SiTF”). In 2016, we were awarded the “Most Innovative Use of Infocomm Technology (Private Sector-SME) Award” by the Infocomm Media Development Authority of Singapore (“IMDA”, formerly known as Infocomm Development Authority) and the SiTF. In 2017, we were awarded the “IP Awards” by the World Intellectual Property Organization — Intellectual Property Office of Singapore (WIPO-IPOS). In addition, in 2017 The Nanyang Technological University of Singapore recognized our innovative solution by publishing it as a case study entitled “The Transformation of Concorde Security Pte Ltd” via its Nanyang Technoprenuership Center. In the same year, the Singapore Management University and Harvard Business Publishing Education also recognized our innovation by publishing a case study entitled “Main Case: The Resilience of a Disruptive Innovator: Concorde Security”. From 2018 to 2019, in recognition of our solution in transforming the industry, the IMDA approved our solutions in the Singapore government’s Industry Transformation Map Pilot Programme. From 2020 to 2021, in recognition of our technology and solutions, we were included in the “Pre-approved IT solutions vendor” under the category of security, by the IMDA. From 2022 to 2023, in recognition of our technology solution, the IMDA approved our solutions in the Singapore government’s Advanced Digital Solutions (ADS) under the Small Medium Enterprises Go Digital Programme. With these awards and recognitions, we believe we are one of the leading solution providers in Singapore. Through the integration of our patented technology solution, we help our clients reduce costs and enhance security. Since our establishment in Singapore in 1997, we have built a track record in the professional security community by consistently providing high-quality security manpower. Recognizing manpower sustainability our ever-advancing society, in 2014, we decided to transit into a security solution services company using our innovative business model. With our patented technological innovation, we deliver a higher level of security performance while requiring fewer personnel. Traditionally, a 24-hour shift would necessitate at least three guards for coverage. Our solution involves deploying CCTV cameras, sensors, and other IoT devices at our clients’ premises to enable remote access control monitoring and management. These devices are integrated and controlled through our mobile command vehicles, known as “I-Man Facility Sprinters (IFS),” which patrol a cluster of client sites within a defined radius. This proactive approach enables swift responses to any incidents that arise. Consequently, our clients have experienced a reduction in the required on-site guards from three to two or even fewer, thanks to the efficient utilization of these technologies. The implementation of CCTV cameras, sensors, and other IoT devices has not only minimized human errors but has also decreased the overall need for additional personnel. Our specialists, tasked with operating the IFS, undergo rigorous training to efficiently handle the diverse technologies and respond adeptly to various situations. This approach not only enhances their skill sets but also contributes to a better work-life balance for our team members. As a result, we have received numerous awards in Singapore, recognizing our innovative technology and our contribution to producing the next generation of reliable security solutions. Anchored by our patented technology applications and pioneering solutions, we provide top-tier security and facilities management services to commercial, financial, industrial, and governmental customers in Singapore. We offer a range of services to enhance security and safety: (1) i-Guarding Services; (2) Man-Guarding Services; and (3) Consultancy and Training Services. Our i-Guarding Services leverages technology to increase efficiency, with a mobile platform and cluster® aggregation model of higher skillset workforce. For the six months ended June 30, 2024 and 2023, our i-Guarding Services accounted for 96.75% and 98.66% of our consolidated revenues, respectively. For the fiscal years ended December 31, 2023 and 2022, our i-Guarding Services accounted for approximately 98.09% and 99.09% of our consolidated revenues, respectively. Man-Guarding Services employs trained security officers to maintain safety and deter unlawful activities. For the six months ended June 30, 2024 and 2023, our Man-Guarding Services accounted for 0.82% and 1.22% of our consolidated revenues, respectively. For the fiscal years ended December 31, 2023 and 2022, it accounted for 1.41% and 0.24% of our consolidated revenues, respectively. Consultancy and Training Services provide expert guidance tailored to clients’ needs. For the six months ended June 30, 2024 and 2023, our Consultancy and Training Services accounted for 0.59% and 0.12% of our consolidated revenues, respectively. For the fiscal years ended December 31, 2023 and 2022, it accounted for 0.50% and 0.67% of our consolidated revenues, respectively. For the six months ended June 30, 2024, our revenue from others accounted for 1.84% of our consolidated revenue, and this was related to a one-off sale of security consumables. There were no such sales in the fiscal years ended December 31, 2023 and 2022. We have gained recognition for our disruptive innovation in the integrated monitoring of properties, assets, and building service systems. This ensures round-the-clock surveillance for complete security and operational efficiency. This achievement is made possible through our suite of intelligent security solutions, known as “I-Guarding Services.” One of our flagship services, the groundbreaking “I-Man Facility Sprinter (“IFS”),” is a mobile vehicular platform that revolutionizes security and facility maintenance services. These pioneering solutions not only improve workers’ compensation, skill sets, and working conditions but also redefine the overall business landscape of the industry. Our company’s second flagship product is the “Intelligent Facility Authenticator (“IFA”).” The IFA is an innovative solution that leverages advanced kiosk technology to enhance security and streamline visitor management. In response to the challenges of limited manpower and rising costs, the IFA system automates the issuance of secure passes and access cards, eliminating the need for physical human interaction. It works by sending secure pass-icons to visitors, verifying their identity upon entry, and dispensing access cards with varying levels of security clearance. This technology not only enhances security within buildings but also offers efficient visitor management services, making it a game-changer in industries where kiosk adoption is increasing. Ultimately, IFA represents a significant advancement in security access control without relying on human intervention. For the six months ended June 30, 2024 and 2023, more than 83% and 98.73% of our revenues were generated by annual recurring contracts, respectively. For the fiscal years ended December 31, 2023 and 2022, more than 96% and 85% of our revenues were generated by annual recurring contract, respectively. 99% of our clients were based in Singapore. For the six months ended June 30, 2024, our top two customers, People’s Association at One Tampines Hub and People’s Association at OnePunggol accounted for approximately 6% and 6% of our total revenue, respectively. For the six months ended June 30, 2023, our top two customers, Singapore University of Technology and Design and People’s Association at OnePunggol accounted for approximately 10% and 8% of our total revenue, respectively. For the fiscal year ended December 31, 2023, our revenue generated by annual recurring contract increased by 11% from 85% in fiscal year 2022 to 96% in fiscal year 2023 as we continued to focus on securing recurring contracts to ensure long-term financial stability and growth. For the fiscal year ended December 31, 2023, our top two customers, Singapore University of Technology and Design and People’s Association at OnePunggol accounted for approximately 8% and 7% of our total revenue, respectively. For the fiscal year ended December 31, 2022, our top two customers, Ceva Logistics Singapore Pte Ltd and JTC Corporation, accounted for approximately 10% and 10% of our total revenue, respectively. Our principal executive office is in Singapore.

National Research stock logo

National Research NASDAQ:NRC

$14.22 -0.73 (-4.88%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$14.37 +0.15 (+1.08%)
As of 07/18/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

ReposiTrak stock logo

ReposiTrak NYSE:TRAK

$18.45 -0.25 (-1.34%)
As of 07/18/2025 03:59 PM Eastern

Park City Group, Inc., a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers. It also provides ScoreTracker, Vendor Managed Inventory, Store Level Ordering and Replenishment, Enterprise Supply Chain Planning, Fresh Market Manager, and ActionManager supply chain solutions to manage inventory, product mix, and labor. In addition, the company offers business-consulting services to suppliers and retailers in the grocery, convenience store, and specialty retail industries, as well as professional consulting services. It primarily serves multi-store retail chains, wholesalers and distributors, and their suppliers. The company is headquartered in Murray, Utah.